From: The efficacy of intracolonic vancomycin for severe Clostridium difficile colitis: a case series
Reference | Number of patients | Hospital setting | Co-morbidities and outcomes | Intracolonic vancomycin dosing regimens per rectum |
---|---|---|---|---|
Current Series | 26 patients over 10 years: 2003 - 2012 | Single VA center, Loma Linda, CA | Median age = 69 years Severity Score Index (range 0–9) = 5.2 suggestive of “moderate” CDI Mean WBC = 27 k 16 patients survived, 10 died | Variable doses ranging from 0.25g q24 h to 1g q6h – most common dose 500 mg q6h |
Saffouri Gastroenterology 2014 [11] | 17 patients over 7 years: 2005–2012. | Single tertiary care teaching hospital, Rochester, MN | Median age = 70 years “Severe” CDI (WBC > 15 k or serum creatinine >1.5x baseline) or “Severe-complicated” CDI (i.e., shock, hypotension, ileus., toxic megacolon or ICU admission) 16 patients survived, 1 died | Variable doses ranging from 0.25g q6 to 1g q6 – most common dose 500 mg q6h |
Kim Surg Infect 2013 [10] | 47 patients over 2.75 years: 2007 - 2009 | Single inner-city hospital, Bronx, NY | Mean age = 65 years “Severe” CDI (any of the following: WBC > 15 k, abdominal tenderness, acidosis) Mean WBC = 27 k 37 patients survived, 10 died | All received 1 g q6h |
Apiusarnthanarkak CID 2002 [6] | 9 cases over 3 years over 3.5 years: 1998 - 2001 | Single tertiary care teaching hospital, St. Louis, MO | Median age = 65 years Mean APACHE II score = 18 (range 12–26) Median WBC = 24 k 8 patients survived, 1 died | Variable doses ranging from 0.5g q4h to 1 g q12h – most common dose 1g q12h |
Shetler Surg Endosc 2001 [9] | 8 cases | Single VA center, Palo Alto, CA | Mean age = 70 years “Severe” CDI all with ileus and toxic megacolon Median WBC = 24 k 3 patients survived, 4 died | All received 0.25g q6h |